Loading…
Medicamen Organics (MEDIORG)₹25.90−2.26%Pharmaceuticals
At the end of the Jun 2026 quarter, Medicamen Organics' shareholders were: promoters 54.86%, FIIs 0.05%, public 45.09%. Promoter holding is down 4.84 percentage points from 59.70% a quarter earlier. FII holding is down 0.09 percentage points from 0.14% a year earlier. 0.00% of promoter shares were pledged. It had 507 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Promoters | 59.66% | 59.70% | 59.70% | 59.70% | 54.86% |
| FIIs | 0.14% | 0.07% | 0.07% | 0.07% | 0.05% |
| DIIs | 3.78% | 3.81% | 3.71% | 1.65% | 0.00% |
| Public | 36.42% | 36.42% | 36.52% | 38.58% | 45.09% |
| Promoter shares pledged | — | — | — | — | 0.00% |
| Number of shareholders | 378 | 459 | 506 | 539 | 507 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Bal Kishan Gupta | Promoter | 48.96% | −3.22 |
| Pradeep Kumar Jain | Public | 13.88% | New |
| Shivani Chopra | Public | 4.04% | New |
| Ashutosh Gupta | Promoter | 3.96% | −1.08 |
| Abhishek Kaushik | Public | 2.11% | +0.91 |
| Ritu Gupta . | Promoter | 1.94% | −0.53 |
| Pawan Kumar Gupta | Public | 1.03% | New |
| Ishaan Gupta | Promoter | 0.05% | −0.01 |
| Sb Opportunities Fund I | DII | Exited | — |
| Akilandeswari Selvamurthy | Public | Exited | — |
Promoters held 54.86% of Medicamen Organics at the end of the Jun 2026 quarter, down 4.80 percentage points from 59.66% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.05% (down 0.02 percentage points from 0.07% a quarter earlier) and domestic institutions (DIIs) held 0.00% (down 1.65 percentage points from 1.65% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Medicamen Organics had 507 shareholders at the end of the Jun 2026 quarter, against 378 a year earlier.
Pradeep Kumar Jain (Public) held 13.88% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.